Item type:Thesis, Open Access

Direkte orale Antikoagulanzien – eine medizinische Innovation oder eine Herausforderung in der Alterstraumatologie? Einblicke in die Praxis & Erkenntnisse rund um das perioperative Management

Loading...
Thumbnail Image

Publisher

Philipps-Universität Marburg

Supervisors

Abstract

Currently, one in ten geriatric trauma patients is permanently anticoagulated. Vitamin K antagonists (VKA) and direct oral anticoagulants (DOAC) are available for oral anticoagulation. DOACs, meanwhile, account for more than 60 % of the prescriptions. These are a relatively new class of agents the anticoagulant effect of which is based on the inhibition of specific coagulation factors (factor (F)- IIa, FXa). Due to lower bleeding risks, shorter half-life periods, no need for regular monitoring and less frequent drug and food interactions, it is foreseeable that DOACs will continue to gain importance and gradually replace the established VKA. In about 15 % of the cases, patients need to interrupt their anticoagulant medication for surgery. Despite increasing experience and existing recommendations, perioperative DOAC management is a challenge in clinical practice. The present study investigated the use of DOAC in the perioperative setting of geriatric traumatology at the Center for Orthopaedics and Trauma Surgery (CfOU) of the University Hospital Giessen and Marburg – Marburg site. In addition to a presentation of the previous perioperative approach, this work was intended to evaluate whether the DOAC use delays the timing of surgery in patients with proximal femur fracture. Further, the adherence to existing recommendations was to be analyzed and a preoperative checklist developed, based on the obtained results. In the retrospective study, the medical records of all >60-year-old patients with a DOAC medication who were hospitalized at the CfOU from 2015–2016 due to a surgical procedure were evaluated. Patient characteristics, surgery-specific parameters (e.g., bleeding risk of the surgery) and aspects of the perioperative course (e.g., occurrence of complications) were examined. In addition to own data, the current state of knowledge determined via a literature search was also taken into account in the development of the checklist for clinical practice. 112 patients (FIIa- Inhibitor: n=19, 17 %; FXa- Inhibitor: n=93, 83 %) with a mean age of 78±8 years were included. The collective consisted of (multi- ) morbid patients under polypharmacy (number of drugs at discharge 10±3) with a high prevalence for a renal function impairment (anamnestic n=20, 17,9 %, laboratory n=66, 74,1 %). The most common indication for a DOAC use was atrial fibrillation (n=68, 73,9 %). 70 % of the primary surgeries were associated with a low bleeding risk. The most common diagnosis was lower extremity fractures (n=28, 30.1 %). The mean duration between the inpatient admission and the surgical care was 34±38 h, and the mean duration of the surgery was 79±53 minutes. The anticoagulant medication was paused perioperatively in 98 % of the patients (preoperative 48±44 h, postoperative 238±240 h). There was no significant difference in the preoperative pause duration subject to the intraoperative bleeding risk (p=0,466). 90 % of the patients received enoxaparin (ClexaneÒ); 60 % of them in a therapeutic dosage, and, thus, underwent bridging. Significant differences in the perioperative approach between the FIIaand FXa- Inhibitor groups were absent. At least one complication occurred postoperatively in 43 % of the patients. Systemic or mechanical complications predominated. Five patients (3,8 %) experienced a bleeding complication, 16 patients (12,1 %) experienced a hemoglobin drop and one patient (0,8 %) experienced a thromboembolic event. A comparison of the perioperative management with existing recommendations revealed a lack of adherence, particularly to the postoperative procedure in terms of prolonging pausing. Patients with high-risk constellations (e.g., severely impaired renal function, high intraoperative bleeding risk), who were managed according to the recommendations, were excluded. The data analysis revealed a variety of factors that should be considered in perioperative management and explored preoperatively. Based on the study results and the literature review, a checklist was developed for the CfOU. A proximal femoral fracture is a common injury in geriatric traumatology, where the timing of the surgery strongly influences the morbidity and the mortality. Therefore, clear guidelines exist for surgical management. The DOAC use is considered a risk factor for delayed surgical care. In the present collective, patients with a proximal femur fracture (16 % of the total collective) underwent surgery significantly (p=0,043) earlier than patients with other injuries. The mean time between the admission and the surgery (17±9 h) was shorter at CfOU than in comparable studies. In sum, the results indicate a heterogeneous approach in the perioperative setting despite clear recommendations. To improve this situation, further prospective studies are needed, especially for nonelective procedures as well as for high-risk constellations. The lack of comparison with nonanticoagulated patients and patients under VKA as well as the lack of differentiation between elective and emergency surgery limits the validity of the study. The developed checklist can help to optimize the perioperative procedure and to increase the patient safety. The checklist could also be useful for the design and data collection of future studies. Ultimately, however, the procedure for each patient remains a case-by-case decision due to his or her individual characteristics and risk factors.

Review

Metadata

show more
Hepper, Alexandra Kim Isabell: Direkte orale Antikoagulanzien – eine medizinische Innovation oder eine Herausforderung in der Alterstraumatologie? Einblicke in die Praxis & Erkenntnisse rund um das perioperative Management. : Philipps-Universität Marburg 2023-06-05. DOI: https://doi.org/10.17192/z2022.0374.

License

This item has been published with the following license: In Copyright